Introduction:

De novo protein sequencing of monoclonal antibodies is required when the cDNA or the original cell line is not available, or when characterization of posttranslational modifications is needed to verify antibody integrity and effectiveness. Complete Omics is proud to offer a series of unrivalled de novo antibody sequencing services for research, diagnostic and therapeutic industries. Complete Omics has developed the proprietary pipeline for antibody protein de novo seqeuncing, MyProt™-ABSeqs™, which is composed by conventional shotgun based database-dependent mass spectrometry sequencing method, and database-independent next generation proteomics de novo sequencing technologies, together with variant identification and de novo PTM profiling capacities.

Data analysis, including data validation, visualization and quantification, are performed with commercial softwares and Complete Omics’ unique R packages and scripts. Report will be sent to you in Excel format as well as a summary in PDF format. We will also provide you any details you need for your papers’ MATERIALS AND METHODS section. We will make sure you understand your result and help you with your paper writing with free follow-up services.

Sample types we accept:

1, 2D gel spots, SDS-PAGE bands

2, Cell Lysates and Tissue Lysates

3, Biofluids, such as plasma*, serum*, saliva, tear, etc.

*We provide High Abundance Protein Depletion Service to significantly (100-500 folds) increase the depth of your biofluid proteomics analysis by removing top abundant proteins from your samples. Read more for details​.

4, FFPE slide/ FFPE extract

5, Customized sample types (please contact us to discuss)

Collaboration with Baylor College of Medicine

Jan 19, 2022 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Andras Attila Heczey and his team from Baylor College of Medicine on a clinical proteomics…

Read more

Collaboration with Washington University in St. Louis

Jan 12, 2022 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Marco Sardiello and his team from Washington University in St. Louis on a clinical proteomics…

Read more

Happy Holidays from Complete Omics!

December 23, 2021 | BALTIMORE – Dear Team Members and Friends: 2021 has been an exciting year for Complete Omics – – we brought dramatic improvements to biomedical sciences and…

Read more

Some of our impacts